| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 49.451 | 19.900 | 28.131 | 1.694 | 0 | 4.570 | 9.674 | 95.086 | 51.589 | 22.660 |
| Total Income - EUR | 49.452 | 21.361 | 28.132 | 1.694 | 0 | 4.635 | 9.674 | 95.197 | 51.643 | 22.736 |
| Total Expenses - EUR | 29.488 | 10.572 | 12.623 | 10.444 | 652 | 4.510 | 946 | 82.322 | 36.853 | 13.674 |
| Gross Profit/Loss - EUR | 19.964 | 10.789 | 15.508 | -8.750 | -652 | 125 | 8.728 | 12.875 | 14.789 | 9.062 |
| Net Profit/Loss - EUR | 18.374 | 10.434 | 15.227 | -8.801 | -652 | 79 | 8.631 | 10.336 | 12.259 | 7.781 |
| Employees | 3 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Axamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 593 | 430 | 269 | 113 | 0 | 0 | 0 | 0 | 0 | 457 |
| Current Assets | 42.125 | 45.994 | 59.126 | 50.583 | 49.315 | 50.096 | 46.873 | 89.534 | 72.657 | 82.372 |
| Inventories | 9.515 | 8.569 | 8.424 | 8.269 | 8.109 | 8.196 | 235 | 2.630 | 1.999 | 3.105 |
| Receivables | 4.975 | 37.345 | 50.451 | 42.315 | 41.232 | 41.860 | 46.589 | 86.746 | 69.726 | 75.488 |
| Cash | 27.635 | 80 | 251 | -2 | -27 | 39 | 49 | 158 | 932 | 3.779 |
| Shareholders Funds | 34.775 | 44.854 | 59.322 | 49.433 | 47.823 | 46.996 | 46.805 | 57.287 | 69.372 | 76.766 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.943 | 1.570 | 73 | 1.263 | 1.492 | 3.100 | 68 | 32.247 | 3.285 | 6.063 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4649 - 4649" | |||||||||
| CAEN Financial Year |
4649
|
|||||||||
Comments - Axamed Srl